Celestial Biolabs financials at a glance
| Year | Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2007 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
202.11M | 192.51M | 215.32M | 252.28M | 205.89M | 211.55M | 235.03M | 274.51M | 328.55M | 386.62M | 428.15M | 489.74M | 0.00M | 141.28M | 0.00M |
| GM % | Gross Margin % |
|
72.27% | 51.27% | 47.15% | 52.28% | 63.23% | 57.76% | 60.83% | 78.22% | 42.31% | 28.22% | 32.98% | 41.40% | 0.00% | 61.57% | 0.00% |
| OM | Operating Margin |
|
46.79% | 36.96% | 12.42% | 11.64% | 2.55% | 4.53% | 11.78% | 19.58% | 8.67% | 9.55% | 9.65% | 4.69% | 0.00% | 36.85% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | ||||||||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
11.19m | 11.19m | 11.19m | 11.78m | 14.6m | 14.6m | 14.6m | 17.35m | 18.56m | 22.59m | 22.59m | 22.59m | 22.59m | 0m | 0m |
| OCF | Operating Cash Flow |
|
-143.31M | 36.03M | 29.23M | 10.28M | 32.25M | 44.76M | 32.70M | 57.86M | 80.25M | 134.04M | 33.37M | 0.00M | 0.00M | 25.66M | 0.00M |
| FCF | Free Cash Flow |
|
0.00M | 14.78M | -67.68M | -142.10M | -101.65M | -6.82M | -12.95M | 21.82M | -13.14M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-13.47 | 1.32 | -5.73 | -12.91 | -11.35 | -1.30 | -2.83 | 1.18 | -1.60 | -0.22 | -0.68 | 0.00 | 0.00 | 4.14 | 0.00 |